Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients

AIM: To assess the efficacy of tenofovir disoproxil fumarate (TDF) in lamivudine (LAM)-resistant patients with a suboptimal response to LAM plus adefovir (ADV). METHODS: We retrospectively analyzed the efficacy of switching to tenofovir disoproxil fumarate in suboptimal responders to lamivudine plus...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastroenterol
Asıl Yazarlar: Yang, Dan-Hong, Xie, Yuan-Jun, Zhao, Nian-Feng, Pan, Hong-Ying, Li, Ming-Wei, Huang, Hai-Jun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2015
Konular:
Retrospective Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351227/
https://ncbi.nlm.nih.gov/pubmed/25759545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i9.2746
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller